Skip to main content

Advertisement

Log in

The far-reaching HAND of cART: cART effects on astrocytes

  • INVITED REVIEW
  • Published:
Journal of Neuroimmune Pharmacology Aims and scope Submit manuscript

Abstract

Following the introduction of combination antiretroviral therapy (cART), the morbidity and mortality from human immunodeficiency virus (HIV) infection has been drastically curtailed and HIV has now become a chronic manageable disease. Persons living with HIV (PLWH) are living longer and experiencing significant co-morbidities and conditions of aging. NeuroHIV, clinically defined as HIV-Associated Neurocognitive Disorders (HAND) and pathologically manifested by persistent inflammation in the CNS despite cART, is a significant co-morbid condition for PLWH. In the pre-cART era, HIV mediated much of the pathogenesis in the Central Nervous System (CNS); in the cART era, with low to undetectable viremia, other mechanisms may be contributing to persistent neuroinflammation. Emerging data point to the adverse effects at the cellular level of cART, independent of HIV. Astrocytes are the most abundant cells in the CNS, playing vital roles in maintaining CNS homeostasis (e.g. metabolic support to neurons, clearance of neurotransmitters, ion balance, modulation of synaptic functions and maintaining the structural integrity of the blood brain barrier (BBB). Therefore, any disruption of their function will have wide repercussions in the CNS. In this review, we will address current knowledge and gaps on the impact of antiretrovirals (ARVs) on astrocytes and physiologic consequences in the CNS. Understanding the status of this field, will provide a practical framework to elucidate the potential role of cART-mediated dysregulation of astrocytes in neuroHIV pathogenesis and inform therapeutic strategies that are “neuro-friendly”.

CNS-penetrating cART have the potential to cause resting astrocytes to become activated into an A1 or neurotoxic phenotype. These cells can in turn secrete inflammatory cytokines that affect surrounding microglia macrophages, as well as neurotoxic factors that impact nearby neurons. In addition, impairment in the physiologic functions of astrocytes will result in altered BBB permeability and disrupted metabolic homeostasis. CNS=Central Nervous System; cART=combined antiretroviral therapy; BBB=blood brain barrier

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Adamson DC, McArthur JC, Dawson TM, Dawson VL (1999) Rate and severity of HIV-associated dementia (HAD): correlations with Gp41 and iNOS. Mol Med 5(2):98–109

    CAS  PubMed  PubMed Central  Google Scholar 

  • Airoldi M, Zaccarelli M, Bisi L, Bini T, Antinori A, Mussini C, Bai F, Orofino G, Sighinolfi L, Gori A, Suter F, Maggiolo F (2010) One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjects. Patient Prefer Adherence 4:115–125

    PubMed  PubMed Central  Google Scholar 

  • Akay C, Cooper M, Odeleye A, Jensen BK, White MG, Vassoler F, Gannon PJ, Mankowski J, Dorsey JL, Buch AM, Cross SA, Cook DR, Pena MM, Andersen ES, Christofidou-Solomidou M, Lindl KA, Zink MC, Clements J, Pierce RC, Kolson DL, Jordan-Sciutto KL (2014) Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system. J Neurovirol 20(1):39–53

    CAS  PubMed  PubMed Central  Google Scholar 

  • Allavena C, Hanf M, Rey D, Duvivier C, BaniSadr F, Poizot-Martin I, Jacomet C, Pugliese P, Delobel P, Katlama C, Joly V, Chidiac C, Dournon N, Merrien D, May T, Reynes J, Gagneux-Brunon A, Chirouze C, Huleux T, Cabie A, Raffi F, A. s. g. Dat (2018) Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patients. PLoS One 13(9):e0203895

    PubMed  PubMed Central  Google Scholar 

  • Anthony IC, Ramage SN, Carnie FW, Simmonds P, Bell JE (2006) Accelerated Tau deposition in the brains of individuals infected with human immunodeficiency virus-1 before and after the advent of highly active anti-retroviral therapy. Acta Neuropathol 111(6):529–538

    CAS  PubMed  Google Scholar 

  • Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69(18):1789–1799

    CAS  PubMed  Google Scholar 

  • Apostolova N, Funes HA, Blas-Garcia A, Alegre F, Polo M, Esplugues JV (2015) Involvement of nitric oxide in the mitochondrial action of efavirenz: a differential effect on neurons and glial cells. J Infect Dis 211(12):1953–1958

    CAS  PubMed  Google Scholar 

  • Arend C, Brandmann M, Dringen R (2013) The antiretroviral protease inhibitor ritonavir accelerates glutathione export from cultured primary astrocytes. Neurochem Res 38(4):732–741

    CAS  PubMed  Google Scholar 

  • Arend C, Rother A, Stolte S, Dringen R (2016) Consequences of a Chronic Exposure of Cultured Brain Astrocytes to the Anti-Retroviral Drug Efavirenz and its Primary Metabolite 8-Hydroxy Efavirenz. Neurochem Res 41(12):3278–3288

    CAS  PubMed  Google Scholar 

  • Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debre P, Leibowitch J (1997) Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 277(5322):112–116

    CAS  PubMed  Google Scholar 

  • Baldwin KT, Eroglu C (2017) Molecular mechanisms of astrocyte-induced synaptogenesis. Curr Opin Neurobiol 45:113–120

  • Begum G, Song S, Wang S, Zhao H, Bhuiyan MIH, Li E, Nepomuceno R, Ye Q, Sun M, Calderon MJ, Stolz DB, Croix CS, Watkins SC, Chen Y, He P, Shull GE, Sun D (2018) Selective knockout of astrocytic Na(+) /H(+) exchanger isoform 1 reduces astrogliosis, BBB damage, infarction, and improves neurological function after ischemic stroke. Glia 66(1):126–144

    PubMed  Google Scholar 

  • Berger JR, Clifford DB (2014) The relationship of CPE to HIV dementia: slain by an ugly fact? Neurology 83(2):109–110

    PubMed  Google Scholar 

  • Bhat R, Crowe EP, Bitto A, Moh M, Katsetos CD, Garcia FU, Johnson FB, Trojanowski JQ, Sell C, Torres C (2012) Astrocyte senescence as a component of Alzheimer's disease. PLoS One 7(9):e45069

    CAS  PubMed  PubMed Central  Google Scholar 

  • Bingham R, Ahmed N, Rangi P, Johnson M, Tyrer M, Green J (2011) HIV encephalitis despite suppressed viraemia: a case of compartmentalized viral escape. Int J STD AIDS 22(10):608–609

    CAS  PubMed  Google Scholar 

  • Bogoch II, Davis BT, Venna N (2011) Reversible dementia in a patient with central nervous system escape of human immunodeficiency virus. J Infect 63(3):236–239

    PubMed  Google Scholar 

  • Bolanos JP, Almeida A (2006) Modulation of astroglial energy metabolism by nitric oxide. Antioxid Redox Signal 8(5-6):955–965

    CAS  PubMed  Google Scholar 

  • Brandmann M, Nehls U, Dringen R (2013) 8-Hydroxy-efavirenz, the primary metabolite of the antiretroviral drug Efavirenz, stimulates the glycolytic flux in cultured rat astrocytes. Neurochem Res 38(12):2524–2534

    CAS  PubMed  Google Scholar 

  • Brandmann M, Tulpule K, Schmidt MM, Dringen R (2012) The antiretroviral protease inhibitors indinavir and nelfinavir stimulate Mrp1-mediated GSH export from cultured brain astrocytes. J Neurochem 120(1):78–92

    CAS  PubMed  Google Scholar 

  • Buniatian G, Traub P, Albinus M, Beckers G, Buchmann A, Gebhardt R, Osswald H (1998) The immunoreactivity of glial fibrillary acidic protein in mesangial cells and podocytes of the glomeruli of rat kidney in vivo and in culture. Biol Cell 90(1):53–61

    CAS  PubMed  Google Scholar 

  • Bush TG, Savidge TC, Freeman TC, Cox HJ, Campbell EA, Mucke L, Johnson MH, Sofroniew MV (1998) Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice. Cell 93(2):189–201

    CAS  PubMed  Google Scholar 

  • Cahn P, Pozniak AL, Mingrone H, Shuldyakov A, Brites C, Andrade-Villanueva JF, Richmond G, Buendia CB, Fourie J, Ramgopal M, Hagins D, Felizarta F, Madruga J, Reuter T, Newman T, Small CB, Lombaard J, Grinsztejn B, Dorey D, Underwood M, Griffith S, Min S, S. S. T. Extended (2013) Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study. Lancet 382(9893):700–708

    CAS  PubMed  Google Scholar 

  • Calcagno A, Simiele M, Motta I, Mornese Pinna S, Bertucci R, D'Avolio A, Di Perri G, Bonora S (2016) Elvitegravir/Cobicistat/Tenofovir/Emtricitabine Penetration in the Cerebrospinal Fluid of Three HIV-Positive Patients. AIDS Res Hum Retroviruses 32(5):409–411

    PubMed  Google Scholar 

  • Campisi J (2013) Aging, cellular senescence, and cancer. Annu Rev Physiol 75:685–705

    CAS  PubMed  Google Scholar 

  • Caniglia EC, Cain LE, Justice A, Tate J, Logan R, Sabin C, Winston A, van Sighem A, Miro JM, Podzamczer D, Olson A, Arribas JR, Moreno S, Meyer L, del Romero J, Dabis F, Bucher HC, Wandeler G, Vourli G, Skoutelis A, Lanoy E, Gasnault J, Costagliola D, Hernan MA, H.-C. Collaboration (2014) Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions. Neurology 83(2):134–141

    PubMed  PubMed Central  Google Scholar 

  • Caron M, Auclairt M, Vissian A, Vigouroux C, Capeau J (2008) Contribution of mitochondrial dysfunction and oxidative stress to cellular premature senescence induced by antiretroviral thymidine analogues. Antivir Ther 13(1):27–38

    CAS  PubMed  Google Scholar 

  • Cassina P, Pehar M, Vargas MR, Castellanos R, Barbeito AG, Estevez AG, Thompson JA, Beckman JS, Barbeito L (2005) Astrocyte activation by fibroblast growth factor-1 and motor neuron apoptosis: implications for amyotrophic lateral sclerosis. J Neurochem 93(1):38–46

    CAS  PubMed  Google Scholar 

  • Chaboub LS, Deneen B (2013) Astrocyte form and function in the developing central nervous system. Semin Pediatr Neurol 20(4):230–235

    PubMed  Google Scholar 

  • Chauhan A, Mehla R, Vijayakumar TS, Handy I (2014) Endocytosis-mediated HIV-1 entry and its significance in the elusive behavior of the virus in astrocytes. Virology 456-457:1–19

    CAS  PubMed  Google Scholar 

  • Chen Q, Fischer A, Reagan JD, Yan LJ, Ames BN (1995) Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc Natl Acad Sci U S A 92(10):4337–4341

    CAS  PubMed  PubMed Central  Google Scholar 

  • Childs BG, Baker DJ, Kirkland JL, Campisi J, van Deursen JM (2014) Senescence and apoptosis: dueling or complementary cell fates? EMBO Rep 15(11):1139–1153

    CAS  PubMed  PubMed Central  Google Scholar 

  • Chinta SJ, Lieu CA, Demaria M, Laberge RM, Campisi J, Andersen JK (2013) Environmental stress, ageing and glial cell senescence: a novel mechanistic link to Parkinson's disease? J Intern Med 273(5):429–436

    CAS  PubMed  PubMed Central  Google Scholar 

  • Ciccarelli N, Fabbiani M, Di Giambenedetto S, Fanti I, Baldonero E, Bracciale L, Tamburrini E, Cauda R, De Luca A, Silveri MC (2011) Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients. Neurology 76(16):1403–1409

    CAS  PubMed  Google Scholar 

  • Clarke LE, Liddelow SA, Chakraborty C, Munch AE, Heiman M, Barres BA (2018) Normal aging induces A1-like astrocyte reactivity. Proc Natl Acad Sci U S A 115(8):E1896–E1905

    CAS  PubMed  PubMed Central  Google Scholar 

  • Cohen J, D'Agostino L, Wilson J, Tuzer F, Torres C (2017) Astrocyte Senescence and Metabolic Changes in Response to HIV Antiretroviral Therapy Drugs. Front Aging Neurosci 9:281

    PubMed  PubMed Central  Google Scholar 

  • Cosenza MA, Zhao ML, Si Q, Lee SC (2002) Human brain parenchymal microglia express CD14 and CD45 and are productively infected by HIV-1 in HIV-1 encephalitis. Brain Pathol 12(4):442–455

    CAS  PubMed  Google Scholar 

  • Cysique LA, Waters EK, Brew BJ (2011) Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research. BMC Neurol 11:148

    PubMed  PubMed Central  Google Scholar 

  • Dahl V, Peterson J, Fuchs D, Gisslen M, Palmer S, Price RW (2014) Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation. AIDS 28(15):2251–2258

    CAS  PubMed  Google Scholar 

  • Deiva K, Khiati A, Hery C, Salim H, Leclerc P, Horellou P, Tardieu M (2006) CCR5-, DC-SIGN-dependent endocytosis and delayed reverse transcription after human immunodeficiency virus type 1 infection in human astrocytes. AIDS Res Hum Retroviruses 22(11):1152–1161

    CAS  PubMed  Google Scholar 

  • DeSilva TM, Borenstein NS, Volpe JJ, Kinney HC, Rosenberg PA (2012) Expression of EAAT2 in neurons and protoplasmic astrocytes during human cortical development. J Comp Neurol 520(17):3912–3932

    CAS  PubMed  PubMed Central  Google Scholar 

  • di Iulio J, Fayet A, Arab-Alameddine M, Rotger M, Lubomirov R, Cavassini M, Furrer H, Gunthard HF, Colombo S, Csajka C, Eap CB, Decosterd LA, Telenti A, Swiss HIVCS (2009) In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 function. Pharmacogenet Genomics 19(4):300–309

    PubMed  Google Scholar 

  • Dilley JW, Schwarcz S, Loeb L, Hsu L, Nelson K, Scheer S (2005) The decline of incident cases of HIV-associated neurological disorders in San Francisco, 1991-2003. AIDS 19(6):634–635

    PubMed  Google Scholar 

  • Dravid AN, Natrajan K, Kulkarni MM, Saraf CK, Mahajan US, Kore SD, Rathod NM, Mahajan US, Wadia RS (2018) Discordant CSF/plasma HIV-1 RNA in individuals on virologically suppressive antiretroviral therapy in Western India. Medicine (Baltimore) 97(8):e9969

    CAS  Google Scholar 

  • Dringen R, Pawlowski PG, Hirrlinger J (2005) Peroxide detoxification by brain cells. J Neurosci Res 79(1-2):157–165

    CAS  PubMed  Google Scholar 

  • Drukarch B, Schepens E, Jongenelen CA, Stoof JC, Langeveld CH (1997) Astrocyte-mediated enhancement of neuronal survival is abolished by glutathione deficiency. Brain Res 770(1-2):123–130

    CAS  PubMed  Google Scholar 

  • Durand M, Chartrand-Lefebvre C, Baril JG, Trottier S, Trottier B, Harris M, Walmsley S, Conway B, Wong A, Routy JP, Kovacs C, MacPherson PA, Monteith KM, Mansour S, Thanassoulis G, Abrahamowicz M, Zhu Z, Tsoukas C, Ancuta P, Bernard N, Tremblay CL, H. I. V. investigators of the Canadian and S. Aging Cohort (2017) The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol. BMC Infect Dis 17(1):611

    PubMed  PubMed Central  Google Scholar 

  • Eden A, Fuchs D, Hagberg L, Nilsson S, Spudich S, Svennerholm B, Price RW, Gisslen M (2010) HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment. J Infect Dis 202(12):1819–1825

    CAS  PubMed  PubMed Central  Google Scholar 

  • Elkin, S. (n.d.) "New generation of non-nucleoside RT HIV inhibitiors avoiding HIV-associated neurocognitive disorders "https://projectreporter.nih.gov/project_info_description.cfm?aid=9352390&icde=45625697&ddparam=&ddvalue=&ddsub=&cr=2&csb=default&cs=ASC&pball=.

  • Ellis RJ, Letendre S, Vaida F, Haubrich R, Heaton RK, Sacktor N, Clifford DB, Best BM, May S, Umlauf A, Cherner M, Sanders C, Ballard C, Simpson DM, Jay C, McCutchan JA (2014) Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder. Clin Infect Dis 58(7):1015–1022

    CAS  PubMed  Google Scholar 

  • Erfle V, Stoeckbauer P, Kleinschmidt A, Kohleisen B, Mellert W, Stavrou D, Brack-Werner R (1991) Target cells for HIV in the central nervous system: macrophages or glial cells? Res Virol 142(2-3):139–144

    CAS  PubMed  Google Scholar 

  • Filipowicz AR, McGary CM, Holder GE, Lindgren AA, Johnson EM, Sugimoto C, Kuroda MJ, Kim WK (2016) Proliferation of Perivascular Macrophages Contributes to the Development of Encephalitic Lesions in HIV-Infected Humans and in SIV-Infected Macaques. Sci Rep 6:32900

    CAS  PubMed  PubMed Central  Google Scholar 

  • Fischer-Smith T, Croul S, Sverstiuk AE, Capini C, L'Heureux D, Regulier EG, Richardson MW, Amini S, Morgello S, Khalili K, Rappaport J (2001) CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J Neurovirol 7(6):528–541

    CAS  PubMed  Google Scholar 

  • Fitch KV, Feldpausch MN, Looby SE (2017) Biomarkers and Clinical Indices of Aging with HIV. Interdiscip Top Gerontol Geriatr 42:47–58

    PubMed  Google Scholar 

  • Funes HA, Blas-Garcia A, Esplugues JV, Apostolova N (2015) Efavirenz alters mitochondrial respiratory function in cultured neuron and glial cell lines. J Antimicrob Chemother 70(8):2249–2254

    CAS  PubMed  Google Scholar 

  • Gallant JE, Thompson M, DeJesus E, Voskuhl GW, Wei X, Zhang H, White K, Cheng A, Quirk E, Martin H (2017) Antiviral Activity, Safety, and Pharmacokinetics of Bictegravir as 10-Day Monotherapy in HIV-1-Infected Adults. J Acquir Immune Defic Syndr 75(1):61–66

    CAS  PubMed  PubMed Central  Google Scholar 

  • Garcia AD, Doan NB, Imura T, Bush TG, Sofroniew MV (2004) GFAP-expressing progenitors are the principal source of constitutive neurogenesis in adult mouse forebrain. Nat Neurosci 7(11):1233–1241

    CAS  PubMed  Google Scholar 

  • Gegg ME, Clark JB, Heales SJ (2005) Co-culture of neurones with glutathione deficient astrocytes leads to increased neuronal susceptibility to nitric oxide and increased glutamate-cysteine ligase activity. Brain Res 1036(1-2):1–6

    CAS  PubMed  Google Scholar 

  • Gianella S, Kosakovsky Pond SL, Oliveira MF, Scheffler K, Strain MC, De la Torre A, Letendre S, Smith DM, Ellis RJ (2016) Compartmentalized HIV rebound in the central nervous system after interruption of antiretroviral therapy. Virus Evol 2(2):vew020

    PubMed  PubMed Central  Google Scholar 

  • Giunta B, Ehrhart J, Obregon DF, Lam L, Le L, Jin J, Fernandez F, Tan J, Shytle RD (2011) Antiretroviral medications disrupt microglial phagocytosis of beta-amyloid and increase its production by neurons: implications for HIV-associated neurocognitive disorders. Mol Brain 4(1):23

    CAS  PubMed  PubMed Central  Google Scholar 

  • Hao HN, Lyman WD (1999) HIV infection of fetal human astrocytes: the potential role of a receptor-mediated endocytic pathway. Brain Res 823(1-2):24–32

    CAS  PubMed  Google Scholar 

  • Harouse JM, Kunsch C, Hartle HT, Laughlin MA, Hoxie JA, Wigdahl B, Gonzalez-Scarano F (1989) CD4-independent infection of human neural cells by human immunodeficiency virus type 1. J Virol 63(6):2527–2533

    CAS  PubMed  PubMed Central  Google Scholar 

  • Hartmann K, Sepulveda-Falla D, Rose IVL, Madore C, Muth C, Matschke J, Butovsky O, Liddelow S, Glatzel M, Krasemann S (2019) Complement 3(+)-astrocytes are highly abundant in prion diseases, but their abolishment led to an accelerated disease course and early dysregulation of microglia. Acta Neuropathol Commun 7(1):83

    PubMed  PubMed Central  Google Scholar 

  • Hayati M, Nouri M, Haghiri S, Abbott D (2016) A Digital Realization of Astrocyte and Neural Glial Interactions. IEEE Trans Biomed Circuits Syst 10(2):518–529

    PubMed  Google Scholar 

  • He J, Chen Y, Farzan M, Choe H, Ohagen A, Gartner S, Busciglio J, Yang X, Hofmann W, Newman W, Mackay CR, Sodroski J, Gabuzda D (1997) CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385(6617):645–649

    CAS  PubMed  Google Scholar 

  • Heaton RK, Franklin DR Jr, Deutsch R, Letendre S, Ellis RJ, Casaletto K, Marquine MJ, Woods SP, Vaida F, Atkinson JH, Marcotte TD, McCutchan JA, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor N, Morgello S, Simpson DM, Abramson I, Gamst AC, Fennema-Notestine C, Smith DM, Grant I, C. Group (2015) Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. Clin Infect Dis 60(3):473–480

    CAS  PubMed  Google Scholar 

  • Henrich TJ, Lelievre JD (2018) Progress towards obtaining an HIV cure: slow but sure. Curr Opin HIV AIDS 13(5):381–382

    PubMed  Google Scholar 

  • Hinkle DA, Harney JP, Cai A, Hilt DC, Yarowsky PJ, Wise PM (1998) Basic fibroblast growth factor-2 and interleukin-1 beta regulate S100 beta expression in cultured astrocytes. Neuroscience 82(1):33–41

    CAS  PubMed  Google Scholar 

  • Hirrlinger J, Dringen R (2010) The cytosolic redox state of astrocytes: Maintenance, regulation and functional implications for metabolite trafficking. Brain Res Rev 63(1-2):177–188

    CAS  PubMed  Google Scholar 

  • Hirrlinger J, Schulz JB, Dringen R (2002) Glutathione release from cultured brain cells: multidrug resistance protein 1 mediates the release of GSH from rat astroglial cells. J Neurosci Res 69(3):318–326

    CAS  PubMed  Google Scholar 

  • Hirsch HH, Kaufmann G, Sendi P, Battegay M (2004) Immune reconstitution in HIV-infected patients. Clin Infect Dis 38(8):1159–1166

    PubMed  Google Scholar 

  • Hogg RS, Yip B, Kully C, Craib KJ, O'Shaughnessy MV, Schechter MT, Montaner JS (1999) Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens. CMAJ 160(5):659–665

    CAS  PubMed  PubMed Central  Google Scholar 

  • Honnapurmath VK, Patil VW (2017) Antiretroviral Therapy-induced Insulin Resistance and Oxidative Deoxy Nucleic Acid Damage in Human Immunodeficiency Virus-1 Patients. Indian J Endocrinol Metab 21(2):316–321

    CAS  PubMed  PubMed Central  Google Scholar 

  • http://naco.gov.in/nacp (2018). "National Technical Guidelines on Anti Retroviral Treatment. National AIDS Control Programme Care Support and Treatment Services-National AIDS Control Organization Ministry of Health and Family Welfare Government of India. Last accessed 3/2019."

  • https://aidsinfo.nih.gov/guidelines "Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV. Panel on Antiretroviral Guidelines for Adults and Adolescents." Accessed 3/20/2019.

  • Hukezalie KR, Thumati NR, Cote HC, Wong JM (2012) In vitro and ex vivo inhibition of human telomerase by anti-HIV nucleoside reverse transcriptase inhibitors (NRTIs) but not by non-NRTIs. PLoS One 7(11):e47505

    CAS  PubMed  PubMed Central  Google Scholar 

  • Ishii T, Ueyama T, Shigyo M, Kohta M, Kondoh T, Kuboyama T, Uebi T, Hamada T, Gutmann DH, Aiba A, Kohmura E, Tohda C, Saito N (2017) A Novel Rac1-GSPT1 Signaling Pathway Controls Astrogliosis Following Central Nervous System Injury. J Biol Chem 292(4):1240–1250

    CAS  PubMed  Google Scholar 

  • Kakuda TN (2000) Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clin Ther 22(6):685–708

    CAS  PubMed  Google Scholar 

  • Kang C, Xu Q, Martin TD, Li MZ, Demaria M, Aron L, Lu T, Yankner BA, Campisi J, Elledge SJ (2015) The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4. Science 349(6255):aaa5612

    PubMed  PubMed Central  Google Scholar 

  • Kaufmann GR, Zaunders J, Cooper DA (1999) Immune reconstitution in HIV-1 infected subjects treated with potent antiretroviral therapy. Sex Transm Infect 75(4):218–224

    CAS  PubMed  PubMed Central  Google Scholar 

  • Khakh BS, Sofroniew MV (2014) Astrocytes and Huntington's disease. ACS Chem Neurosci 5(7):494–496

    CAS  PubMed  PubMed Central  Google Scholar 

  • Koh W, Park YM, Lee SE, Lee CJ (2017) AAV-Mediated Astrocyte-Specific Gene Expression under Human ALDH1L1 Promoter in Mouse Thalamus. Exp Neurobiol 26(6):350–361

    PubMed  PubMed Central  Google Scholar 

  • Kolgiri V, Nagar V, Patil V (2018) Association of Metabolic Syndrome and Oxidative DNA Damage in HIV/AIDS Patients. Indian J Clin Biochem 33(3):273–281

    CAS  PubMed  Google Scholar 

  • Kolgiri V, Patil VW (2017) Protein carbonyl content: a novel biomarker for aging in HIV/AIDS patients. Braz J Infect Dis 21(1):35–41

    PubMed  Google Scholar 

  • Lagathu C, Eustace B, Prot M, Frantz D, Gu Y, Bastard JP, Maachi M, Azoulay S, Briggs M, Caron M, Capeau J (2007) Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages. Antivir Ther 12(4):489–500

    CAS  PubMed  Google Scholar 

  • Latronico T, Pati I, Ciavarella R, Fasano A, Mengoni F, Lichtner M, Vullo V, Mastroianni CM, Liuzzi GM (2018) In vitro effect of antiretroviral drugs on cultured primary astrocytes: analysis of neurotoxicity and matrix metalloproteinase inhibition. J Neurochem 144(3):271–284

    CAS  PubMed  Google Scholar 

  • Lebon V, Petersen KF, Cline GW, Shen J, Mason GF, Dufour S, Behar KL, Shulman GI, Rothman DL (2002) Astroglial contribution to brain energy metabolism in humans revealed by 13C nuclear magnetic resonance spectroscopy: elucidation of the dominant pathway for neurotransmitter glutamate repletion and measurement of astrocytic oxidative metabolism. J Neurosci 22(5):1523–1531

    CAS  PubMed  PubMed Central  Google Scholar 

  • Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Morgello S, Simpson D, Grant I, Ellis RJ, C. Group (2008) Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 65(1):65–70

    PubMed  PubMed Central  Google Scholar 

  • Letendre SL, Mills AM, Tashima KT, Thomas DA, Min SS, Chen S, Song IH, Piscitelli SC, I. N. G. S. T. Extended (2014) ING116070: a study of the pharmacokinetics and antiviral activity of dolutegravir in cerebrospinal fluid in HIV-1-infected, antiretroviral therapy-naive subjects. Clin Infect Dis 59(7):1032–1037

    CAS  PubMed  PubMed Central  Google Scholar 

  • Levy ME, Greenberg AE, Hart R, Powers Happ L, Hadigan C, Castel A, D. C. C. E. Committee (2017) High burden of metabolic comorbidities in a citywide cohort of HIV outpatients: evolving health care needs of people aging with HIV in Washington, DC. HIV Med 18(10):724–735

    CAS  PubMed  PubMed Central  Google Scholar 

  • Levy RM, Bredesen DE, Rosenblum ML (1985) Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg 62(4):475–495

    CAS  PubMed  Google Scholar 

  • Li W, Henderson LJ, Major EO, Al-Harthi L (2011) IFN-gamma mediates enhancement of HIV replication in astrocytes by inducing an antagonist of the beta-catenin pathway (DKK1) in a STAT 3-dependent manner. J Immunol 186(12):6771–6778

    CAS  PubMed  Google Scholar 

  • Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, Bennett ML, Munch AE, Chung WS, Peterson TC, Wilton DK, Frouin A, Napier BA, Panicker N, Kumar M, Buckwalter MS, Rowitch DH, Dawson VL, Dawson TM, Stevens B, Barres BA (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541(7638):481–487

    CAS  PubMed  PubMed Central  Google Scholar 

  • Liu Y, Liu H, Kim BO, Gattone VH, Li J, Nath A, Blum J, He JJ (2004) CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor. J Virol 78(8):4120–4133

    CAS  PubMed  PubMed Central  Google Scholar 

  • Luo X, He JJ (2015) Cell-cell contact viral transfer contributes to HIV infection and persistence in astrocytes. J Neurovirol 21(1):66–80

    CAS  PubMed  Google Scholar 

  • Lutgen V, Narasipura SD, Sharma A, Min S, Al-Harthi L (2016) beta-Catenin signaling positively regulates glutamate uptake and metabolism in astrocytes. J Neuroinflammation 13(1):242

    PubMed  PubMed Central  Google Scholar 

  • Maggiolo F, Ripamonti D, Gregis G, Quinzan G, Callegaro A, Arici C, Ravasio L, Suter F (2003) Once-a-day therapy for HIV infection: a controlled, randomized study in antiretroviral-naive HIV-1-infected patients. Antivir Ther 8(4):339–346

    CAS  PubMed  Google Scholar 

  • Margolis DM (2017) Towards an HIV Cure: a View of a Developing Field. J Infect Dis 215(suppl_3):S109–S110

    PubMed  PubMed Central  Google Scholar 

  • Marra CM, Zhao Y, Clifford DB, Letendre S, Evans S, Henry K, Ellis RJ, Rodriguez B, Coombs RW, Schifitto G, McArthur JC, Robertson K, Team ACTGS (2009) Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. AIDS 23(11):1359–1366

    PubMed  Google Scholar 

  • Martinez-Arroyo O, Gruevska A, Victor VM, Gonzalez-Polo RA, Yakhine-Diop SMS, Fuentes JM, Esplugues JV, Blas-Garcia A, Apostolova N (2019) Mitophagy in human astrocytes treated with the antiretroviral drug Efavirenz: Lack of evidence or evidence of the lack. Antiviral Res 168:36–50

    CAS  PubMed  Google Scholar 

  • Matinella A, Lanzafame M, Bonometti MA, Gajofatto A, Concia E, Vento S, Monaco S, Ferrari S (2015) Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study. J Neurol 262(5):1317–1327

    CAS  PubMed  Google Scholar 

  • Mena MA, Casarejos MJ, Garcia de Yebenes J (1999) The effect of glia-conditioned medium on dopamine neurons in culture. Modulation of apoptosis, tyrosine hydroxylase expression and 1-methyl-4-phenylpyridinium toxicity. J Neural Transm (Vienna) 106(11-12):1105–1123

    CAS  Google Scholar 

  • Minich T, Riemer J, Schulz JB, Wielinga P, Wijnholds J, Dringen R (2006) The multidrug resistance protein 1 (Mrp1), but not Mrp5, mediates export of glutathione and glutathione disulfide from brain astrocytes. J Neurochem 97(2):373–384

    CAS  PubMed  Google Scholar 

  • Molina JM, Andrade-Villanueva J, Echevarria J, Chetchotisakd P, Corral J, David N, Moyle G, Mancini M, Percival L, Yang R, Thiry A, McGrath D, Team CS (2008) Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study. Lancet 372(9639):646–655

    CAS  PubMed  Google Scholar 

  • Molina JM, Clotet B, van Lunzen J, Lazzarin A, Cavassini M, Henry K, Kulagin V, Givens N, de Oliveira CF, Brennan C, F. s. team (2015) Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study. Lancet HIV 2(4):e127–e136

    PubMed  Google Scholar 

  • Mondal D, Pradhan L, Ali M, Agrawal KC (2004) HAART drugs induce oxidative stress in human endothelial cells and increase endothelial recruitment of mononuclear cells: exacerbation by inflammatory cytokines and amelioration by antioxidants. Cardiovasc Toxicol 4(3):287–302

    CAS  PubMed  Google Scholar 

  • Morizawa YM, Hirayama Y, Ohno N, Shibata S, Shigetomi E, Sui Y, Nabekura J, Sato K, Okajima F, Takebayashi H, Okano H, Koizumi S (2017) Reactive astrocytes function as phagocytes after brain ischemia via ABCA1-mediated pathway. Nat Commun 8(1):28

    PubMed  PubMed Central  Google Scholar 

  • Mosepele M, Mohammed T, Mupfumi L, Moyo S, Bennett K, Lockman S, Hemphill LC, Triant VA (2018) HIV disease is associated with increased biomarkers of endothelial dysfunction despite viral suppression on long-term antiretroviral therapy in Botswana. Cardiovasc J Afr 29(3):155–161

    PubMed  PubMed Central  Google Scholar 

  • Nagele RG, Wegiel J, Venkataraman V, Imaki H, Wang KC, Wegiel J (2004) Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease. Neurobiol Aging 25(5):663–674

    CAS  PubMed  Google Scholar 

  • Narasipura SD, Kim S, Al-Harthi L (2014) Epigenetic regulation of HIV-1 latency in astrocytes. J Virol 88(5):3031–3038

    PubMed  PubMed Central  Google Scholar 

  • Nedergaard M, Ransom B, Goldman SA (2003) New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci 26(10):523–530

    CAS  PubMed  Google Scholar 

  • Neubauer K, Knittel T, Aurisch S, Fellmer P, Ramadori G (1996) Glial fibrillary acidic protein--a cell type specific marker for Ito cells in vivo and in vitro. J Hepatol 24(6):719–730

    CAS  PubMed  Google Scholar 

  • Nooka S, Ghorpade A (2017) HIV-1-associated inflammation and antiretroviral therapy regulate astrocyte endoplasmic reticulum stress responses. Cell Death Discov 3:17061

    CAS  PubMed  PubMed Central  Google Scholar 

  • O'Callaghan JP, Kelly KA, VanGilder RL, Sofroniew MV, Miller DB (2014) Early activation of STAT3 regulates reactive astrogliosis induced by diverse forms of neurotoxicity. PLoS One 9(7):e102003

    PubMed  PubMed Central  Google Scholar 

  • Onen NF, Overton ET, Seyfried W, Stumm ER, Snell M, Mondy K, Tebas P (2010) Aging and HIV infection: a comparison between older HIV-infected persons and the general population. HIV Clin Trials 11(2):100–109

    PubMed  Google Scholar 

  • Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338(13):853–860

    PubMed  Google Scholar 

  • Pelchen-Matthews A, Ryom L, Borges AH, Edwards S, Duvivier C, Stephan C, Sambatakou H, Maciejewska K, Portu JJ, Weber J, Degen O, Calmy A, Reikvam DH, Jevtovic D, Wiese L, Smidt J, Smiatacz T, Hassoun G, Kuznetsova A, Clotet B, Lundgren J, Mocroft A, S. s. Euro (2018) Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort. AIDS 32(16):2405–2416

    PubMed  Google Scholar 

  • Peluso MJ, Ferretti F, Peterson J, Lee E, Fuchs D, Boschini A, Gisslen M, Angoff N, Price RW, Cinque P, Spudich S (2012) Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load. AIDS 26(14):1765–1774

    CAS  PubMed  Google Scholar 

  • Peluso R, Haase A, Stowring L, Edwards M, Ventura P (1985) A Trojan Horse mechanism for the spread of visna virus in monocytes. Virology 147(1):231–236

    CAS  PubMed  Google Scholar 

  • Perez-Alvarez A, Navarrete M, Covelo A, Martin ED, Araque A (2014) Structural and functional plasticity of astrocyte processes and dendritic spine interactions. J Neurosci 34(38):12738–12744

    PubMed  PubMed Central  Google Scholar 

  • Rasmussen LD, May MT, Kronborg G, Larsen CS, Pedersen C, Gerstoft J, Obel N (2015) Time trends for risk of severe age-related diseases in individuals with and without HIV infection in Denmark: a nationwide population-based cohort study. Lancet HIV 2(7):e288–e298

    PubMed  Google Scholar 

  • Rasola A, Bernardi P (2011) Mitochondrial permeability transition in Ca(2+)-dependent apoptosis and necrosis. Cell Calcium 50(3):222–233

    CAS  PubMed  Google Scholar 

  • Reilly JF, Maher PA, Kumari VG (1998) Regulation of astrocyte GFAP expression by TGF-beta1 and FGF-2. Glia 22(2):202–210

    CAS  PubMed  Google Scholar 

  • Richards MH, Narasipura SD, Kim S, Seaton MS, Lutgen V, Al-Harthi L (2015) Dynamic interaction between astrocytes and infiltrating PBMCs in context of neuroAIDS. Glia 63(3):441–451

    PubMed  Google Scholar 

  • Robertson K, Liner J, Meeker RB (2012) Antiretroviral neurotoxicity. J Neurovirol 18(5):388–399

    CAS  PubMed  PubMed Central  Google Scholar 

  • Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, Wu J, McArthur JC, Collier AC, Evans SR, Ellis RJ (2007) The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS 21(14):1915–1921

    PubMed  Google Scholar 

  • Robertson KR, Su Z, Margolis DM, Krambrink A, Havlir DV, Evans S, Skiest DJ, Team AS (2010) Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort. Neurology 74(16):1260–1266

    CAS  PubMed  PubMed Central  Google Scholar 

  • Rodriguez-Vieitez E, Saint-Aubert L, Carter SF, Almkvist O, Farid K, Scholl M, Chiotis K, Thordardottir S, Graff C, Wall A, Langstrom B, Nordberg A (2016) Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease. Brain 139(Pt 3):922–936

    PubMed  PubMed Central  Google Scholar 

  • Rossi D, Brambilla L, Valori CF, Roncoroni C, Crugnola A, Yokota T, Bredesen DE, Volterra A (2008) Focal degeneration of astrocytes in amyotrophic lateral sclerosis. Cell Death Differ 15(11):1691–1700

    CAS  PubMed  Google Scholar 

  • Rotger M, Colombo S, Furrer H, Bleiber G, Buclin T, Lee BL, Keiser O, Biollaz J, Decosterd L, Telenti A, Swiss HIVCS (2005) Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients. Pharmacogenet Genomics 15(1):1–5

    CAS  PubMed  Google Scholar 

  • Rotger M, Tegude H, Colombo S, Cavassini M, Furrer H, Decosterd L, Blievernicht J, Saussele T, Gunthard HF, Schwab M, Eichelbaum M, Telenti A, Zanger UM (2007) Predictive value of known and novel alleles of CYP2B6 for efavirenz plasma concentrations in HIV-infected individuals. Clin Pharmacol Ther 81(4):557–566

    CAS  PubMed  Google Scholar 

  • Rottman JB, Ganley KP, Williams K, Wu L, Mackay CR, Ringler DJ (1997) Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection. Am J Pathol 151(5):1341–1351

    CAS  PubMed  PubMed Central  Google Scholar 

  • Russell RA, Chojnacki J, Jones DM, Johnson E, Do T, Eggeling C, Padilla-Parra S, Sattentau QJ (2017) Astrocytes Resist HIV-1 Fusion but Engulf Infected Macrophage Material. Cell Rep 18(6):1473–1483

    CAS  PubMed  PubMed Central  Google Scholar 

  • Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, Becker JT, Cohen B, McArthur JC, Multicenter ACS (2001) HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998. Neurology 56(2):257–260

    CAS  PubMed  Google Scholar 

  • Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, McArthur JC, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida JA, Cohen B, Epstein L (2002) HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol 8(2):136–142

    PubMed  Google Scholar 

  • Sacktor N, Skolasky RL, Seaberg E, Munro C, Becker JT, Martin E, Ragin A, Levine A, Miller E (2016) Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study. Neurology 86(4):334–340

    CAS  PubMed  PubMed Central  Google Scholar 

  • Saksena NK, Smit TK (2005) HAART & the molecular biology of AIDS dementia complex. Indian J Med Res 121(4):256–269

    CAS  PubMed  Google Scholar 

  • Saylor D, Dickens AM, Sacktor N, Haughey N, Slusher B, Pletnikov M, Mankowski JL, Brown A, Volsky DJ, McArthur JC (2016) HIV-associated neurocognitive disorder - pathogenesis and prospects for treatment. Nat Rev Neurol 12(5):309

    PubMed  PubMed Central  Google Scholar 

  • Shuter J, Sarlo JA, Kanmaz TJ, Rode RA, Zingman BS (2007) HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%. J Acquir Immune Defic Syndr 45(1):4–8

    CAS  PubMed  Google Scholar 

  • Simmons R, Kall M, Collins S, Cairns G, Taylor S, Nelson M, Fidler S, Porter K, Fox J, H. I. V. E. o. v. R. S. c. Collaborative (2017) A global survey of HIV-positive people's attitudes towards cure research. HIV Med 18(2):73–79

    CAS  PubMed  Google Scholar 

  • Soontornniyomkij V, Umlauf A, Soontornniyomkij B, Gouaux B, Ellis RJ, Levine AJ, Moore DJ, Letendre SL (2018) Association of antiretroviral therapy with brain aging changes among HIV-infected adults. AIDS 32(14):2005–2015

    PubMed  Google Scholar 

  • Sprague C, Brown SM (2017) Local and Global HIV Aging Demographics and Research. Interdiscip Top Gerontol Geriatr 42:1–10

    PubMed  Google Scholar 

  • Spudich S, Gisslen M, Hagberg L, Lee E, Liegler T, Brew B, Fuchs D, Tambussi G, Cinque P, Hecht FM, Price RW (2011) Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden. J Infect Dis 204(5):753–760

    CAS  PubMed  PubMed Central  Google Scholar 

  • Spudich S, Robertson KR, Bosch RJ, Gandhi RT, Cyktor JC, Mar H, Macatangay BJ, Lalama CM, Rinaldo C, Collier AC, Godfrey C, Eron JJ, McMahon D, Jacobs JL, Koontz D, Hogg E, Vecchio A, Mellors JW (2019) "Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance." J Clin Invest 130

  • Stobart JL, Anderson CM (2013) Multifunctional role of astrocytes as gatekeepers of neuronal energy supply. Front Cell Neurosci 7:38

    CAS  PubMed  PubMed Central  Google Scholar 

  • Strijdom H, De Boever P, Walzl G, Essop MF, Nawrot TS, Webster I, Westcott C, Mashele N, Everson F, Malherbe ST, Stanley K, Kessler HH, Stelzl E, Goswami N (2017) Cardiovascular risk and endothelial function in people living with HIV/AIDS: design of the multi-site, longitudinal EndoAfrica study in the Western Cape Province of South Africa. BMC Infect Dis 17(1):41

    PubMed  PubMed Central  Google Scholar 

  • Sutton SS, Magagnoli J, Hardin JW (2017) Odds of Viral Suppression by Single-Tablet Regimens, Multiple-Tablet Regimens, and Adherence Level in HIV/AIDS Patients Receiving Antiretroviral Therapy. Pharmacotherapy 37(2):204–213

    CAS  PubMed  Google Scholar 

  • Tanabe S, Heesen M, Yoshizawa I, Berman MA, Luo Y, Bleul CC, Springer TA, Okuda K, Gerard N, Dorf ME (1997) Functional expression of the CXC-chemokine receptor-4/fusin on mouse microglial cells and astrocytes. J Immunol 159(2):905–911

    CAS  PubMed  Google Scholar 

  • Tansey FA, Farooq M, Cammer W (1991) Glutamine synthetase in oligodendrocytes and astrocytes: new biochemical and immunocytochemical evidence. J Neurochem 56(1):266–272

    CAS  PubMed  Google Scholar 

  • Tarassishin L, Suh HS, Lee SC (2014) LPS and IL-1 differentially activate mouse and human astrocytes: role of CD14. Glia 62(6):999–1013

    PubMed  PubMed Central  Google Scholar 

  • Thaker HK, Snow MH (2003) HIV viral suppression in the era of antiretroviral therapy. Postgrad Med J 79(927):36–42

    CAS  PubMed  PubMed Central  Google Scholar 

  • Thompson KA, Churchill MJ, Gorry PR, Sterjovski J, Oelrichs RB, Wesselingh SL, McLean CA (2004) Astrocyte specific viral strains in HIV dementia. Ann Neurol 56(6):873–877

    CAS  PubMed  Google Scholar 

  • Tornatore C, Nath A, Amemiya K, Major EO (1991) Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta. J Virol 65(11):6094–6100

    CAS  PubMed  PubMed Central  Google Scholar 

  • Tovar-y-Romo LB, Bumpus NN, Pomerantz D, Avery LB, Sacktor N, McArthur JC, Haughey NJ (2012) Dendritic spine injury induced by the 8-hydroxy metabolite of efavirenz. J Pharmacol Exp Ther 343(3):696–703

    CAS  PubMed  PubMed Central  Google Scholar 

  • Tozzi V, Balestra P, Murri R, Galgani S, Bellagamba R, Narciso P, Antinori A, Giulianelli M, Tosi G, Fantoni M, Sampaolesi A, Noto P, Ippolito G, Wu AW (2004) Neurocognitive impairment influences quality of life in HIV-infected patients receiving HAART. Int J STD AIDS 15(4):254–259

    CAS  PubMed  Google Scholar 

  • Tsuchiya K, Ohuchi M, Yamane N, Aikawa H, Gatanaga H, Oka S, Hamada A (2018) High-performance liquid chromatography-tandem mass spectrometry for simultaneous determination of raltegravir, dolutegravir and elvitegravir concentrations in human plasma and cerebrospinal fluid samples. Biomed Chromatogr 32(2)

  • Valcour V, Chalermchai T, Sailasuta N, Marovich M, Lerdlum S, Suttichom D, Suwanwela NC, Jagodzinski L, Michael N, Spudich S, van Griensven F, de Souza M, Kim J, Ananworanich J, R. S. S. Group (2012) Central nervous system viral invasion and inflammation during acute HIV infection. J Infect Dis 206(2):275–282

    CAS  PubMed  PubMed Central  Google Scholar 

  • Vallat AV, De Girolami U, He J, Mhashilkar A, Marasco W, Shi B, Gray F, Bell J, Keohane C, Smith TW, Gabuzda D (1998) Localization of HIV-1 co-receptors CCR5 and CXCR4 in the brain of children with AIDS. Am J Pathol 152(1):167–178

    CAS  PubMed  PubMed Central  Google Scholar 

  • Verkhratsky A, Sofroniew MV, Messing A, deLanerolle NC, Rempe D, Rodriguez JJ, Nedergaard M (2012) "Neurological diseases as primary gliopathies: a reassessment of neurocentrism." ASN Neuro 4(3)

  • Vijaykumar TS, Nath A, Chauhan A (2008) Chloroquine mediated molecular tuning of astrocytes for enhanced permissiveness to HIV infection. Virology 381(1):1–5

    CAS  PubMed  Google Scholar 

  • Villa G, Solida A, Moro E, Tavolozza M, Antinori A, De Luca A, Murri R, Tamburrini E (1996) Cognitive impairment in asymptomatic stages of HIV infection. A longitudinal study. Eur Neurol 36(3):125–133

    CAS  PubMed  Google Scholar 

  • Vitoria M, Hill A, Ford N, Doherty M, Clayden P, Venter F, Ripin D, Flexner C, Domanico PL (2018) The transition to dolutegravir and other new antiretrovirals in low-income and middle-income countries: what are the issues? AIDS 32(12):1551–1561

    PubMed  Google Scholar 

  • Vivithanaporn P, Asahchop EL, Acharjee S, Baker GB, Power C (2016) HIV protease inhibitors disrupt astrocytic glutamate transporter function and neurobehavioral performance. AIDS 30(4):543–552

    CAS  PubMed  Google Scholar 

  • Wang CH, Wu SB, Wu YT, Wei YH (2013) Oxidative stress response elicited by mitochondrial dysfunction: implication in the pathophysiology of aging. Exp Biol Med (Maywood) 238(5):450–460

    Google Scholar 

  • Wang T, Yi R, Green LA, Chelvanambi S, Seimetz M, Clauss M (2015) Increased cardiovascular disease risk in the HIV-positive population on ART: potential role of HIV-Nef and Tat. Cardiovasc Pathol 24(5):279–282

    PubMed  PubMed Central  Google Scholar 

  • Wang X, Chai H, Lin PH, Yao Q, Chen C (2009) Roles and mechanisms of human immunodeficiency virus protease inhibitor ritonavir and other anti-human immunodeficiency virus drugs in endothelial dysfunction of porcine pulmonary arteries and human pulmonary artery endothelial cells. Am J Pathol 174(3):771–781

    CAS  PubMed  PubMed Central  Google Scholar 

  • Wang Z, Pekarskaya O, Bencheikh M, Chao W, Gelbard HA, Ghorpade A, Rothstein JD, Volsky DJ (2003) Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120. Virology 312(1):60–73

    CAS  PubMed  Google Scholar 

  • Wang Z, Trillo-Pazos G, Kim SY, Canki M, Morgello S, Sharer LR, Gelbard HA, Su ZZ, Kang DC, Brooks AI, Fisher PB, Volsky DJ (2004) Effects of human immunodeficiency virus type 1 on astrocyte gene expression and function: potential role in neuropathogenesis. J Neurovirol 10(Suppl 1):25–32

    PubMed  Google Scholar 

  • Ward BA, Gorski JC, Jones DR, Hall SD, Flockhart DA, Desta Z (2003) The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity. J Pharmacol Exp Ther 306(1):287–300

    CAS  PubMed  Google Scholar 

  • Williams KC, Corey S, Westmoreland SV, Pauley D, Knight H, deBakker C, Alvarez X, Lackner AA (2001) Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. J Exp Med 193(8):905–915

    CAS  PubMed  PubMed Central  Google Scholar 

  • Wohl DA, Yazdanpanah Y, Baumgarten A, Clarke A, Thompson MA, Brinson C, Hagins D, Ramgopal MN, Antinori A, Wei X, Acosta R, Collins SE, Brainard D, Martin H (2019) Bictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial. Lancet HIV 6(6):e355–e363

    PubMed  Google Scholar 

  • World Health Organization (2016) Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection https://apps.who.int/iris/bitstream/handle/10665/75188/9789241503884_eng.pdf?sequence=1. Accessed 3/20/2019

  • Xing HQ, Hayakawa H, Gelpi E, Kubota R, Budka H, Izumo S (2009) Reduced expression of excitatory amino acid transporter 2 and diffuse microglial activation in the cerebral cortex in AIDS cases with or without HIV encephalitis. J Neuropathol Exp Neurol 68(2):199–209

    CAS  PubMed  Google Scholar 

  • Xu C, Ogburn ET, Guo Y, Desta Z (2012) Effects of the CYP2B6*6 allele on catalytic properties and inhibition of CYP2B6 in vitro: implication for the mechanism of reduced efavirenz metabolism and other CYP2B6 substrates in vivo. Drug Metab Dispos 40(4):717–725

    CAS  PubMed  PubMed Central  Google Scholar 

  • Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann DH, Takahashi R, Misawa H, Cleveland DW (2008) Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 11(3):251–253

    CAS  PubMed  PubMed Central  Google Scholar 

  • Yilmaz A, Gisslen M, Spudich S, Lee E, Jayewardene A, Aweeka F, Price RW (2009) Raltegravir cerebrospinal fluid concentrations in HIV-1 infection. PLoS One 4(9):e6877

    PubMed  PubMed Central  Google Scholar 

  • Yilmaz A, Price RW, Spudich S, Fuchs D, Hagberg L, Gisslen M (2008) Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy. J Acquir Immune Defic Syndr 47(2):168–173

    PubMed  PubMed Central  Google Scholar 

  • Yu C, Narasipura SD, Richards MH, Hu XT, Yamamoto B, Al-Harthi L (2017) HIV and drug abuse mediate astrocyte senescence in a beta-catenin-dependent manner leading to neuronal toxicity. Aging Cell 16(5):956–965

    CAS  PubMed  PubMed Central  Google Scholar 

  • Yu Z, Yu P, Chen H, Geller HM (2014) Targeted inhibition of KCa3.1 attenuates TGF-beta-induced reactive astrogliosis through the Smad2/3 signaling pathway. J Neurochem 130(1):41–49

    CAS  PubMed  PubMed Central  Google Scholar 

  • Zash R, Makhema J, Shapiro RL (2018) Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception. New England Journal of Medicine 379(10):979–981

    Google Scholar 

  • Zundorf G, Reiser G (2011) Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of neurodegenerative diseases provide multiple targets for neuroprotection. Antioxid Redox Signal 14(7):1275–1288

    PubMed  PubMed Central  Google Scholar 

Download references

Funding

This work is supported by NIH grants RO1MH113425 (LA)

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jennillee Wallace.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gonzalez, H., Podany, A., Al-Harthi, L. et al. The far-reaching HAND of cART: cART effects on astrocytes. J Neuroimmune Pharmacol 16, 144–158 (2021). https://doi.org/10.1007/s11481-020-09907-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11481-020-09907-w

Keywords

Navigation